Dennis Ross-Degnan mainly investigates Public health, Medicaid, Health care, Psychological intervention and Medical prescription. His biological study spans a wide range of topics, including Polypharmacy, Psychiatry, Pediatrics and Gerontology. His Medicaid study combines topics from a wide range of disciplines, such as Reimbursement, Cohort and Drug.
The various areas that Dennis Ross-Degnan examines in his Health care study include Pharmacy, Program evaluation, Public relations and Cost sharing. His Psychological intervention study integrates concerns from other disciplines, such as Health informatics, Collaborative Care and MEDLINE. His Medical prescription research incorporates themes from Adverse effect and Intensive care medicine.
Dennis Ross-Degnan mainly focuses on Family medicine, Health care, Medical prescription, Public health and Medicaid. His Family medicine research includes elements of Psychological intervention, MEDLINE, Intervention, Diabetes mellitus and Deductible. His research in Health care tackles topics such as Environmental health which are related to areas like Socioeconomic status.
His work deals with themes such as Internal medicine, Confidence interval and Emergency medicine, which intersect with Medical prescription. His Public health study frequently involves adjacent topics like Pediatrics. The concepts of his Medicaid study are interwoven with issues in Reimbursement, Psychiatry, Drug, Prior authorization and Medicare Part D.
Dennis Ross-Degnan focuses on Family medicine, Deductible, MEDLINE, Diabetes mellitus and Pharmacy. His Family medicine research includes themes of Essential medicines, Primary health care, Health care, Protocol and Primary outcome. His research integrates issues of Performance indicator and Public sector in his study of Health care.
Dennis Ross-Degnan has researched MEDLINE in several fields, including Quality, Research design, Insulin and Medicare population. His Diabetes mellitus research is multidisciplinary, relying on both mHealth, Observational study, Internal medicine, Intervention and Natural experiment. The study incorporates disciplines such as Christian ministry, Pharmacology toxicology, Psychological intervention and Environmental health in addition to Pharmacy.
Dennis Ross-Degnan spends much of his time researching MEDLINE, Family medicine, Deductible, Diabetes mellitus and Environmental health. His MEDLINE research incorporates elements of Research design, Bipolar disorder, Low and middle income countries and Protocol. Dennis Ross-Degnan combines Family medicine and Health condition in his studies.
In his research, Savings account, Mental health, Propensity score matching, Longitudinal study and Psychological intervention is intimately related to Pharmacy, which falls under the overarching field of Deductible. His research in Diabetes mellitus intersects with topics in Insurance claims, Survival analysis and Cohort study. His Environmental health research is multidisciplinary, incorporating elements of Odds ratio, Subsidy, Survey data collection and Medicare population.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Segmented regression analysis of interrupted time series studies in medication use research
A. K. Wagner;S. B. Soumerai;F. Zhang;D. Ross-Degnan.
Journal of Clinical Pharmacy and Therapeutics (2002)
Medicine prices, availability, and affordability in 36 developing and middle-income countries: a secondary analysis.
A Cameron;M Ewen;D Ross-Degnan;D Ball.
The Lancet (2009)
Evidence of self-report bias in assessing adherence to guidelines.
Alyce S. Adams;Stephen B. Soumerai;Jonathan Lomas;Dennis Ross-Degnan.
International Journal for Quality in Health Care (1999)
Effects of Medicaid drug-payment limits on admission to hospitals and nursing homes.
Stephen Bertram Soumerai;Dennis Ross-Degnan;Jerry Lewis Avorn;Thomas J. McLaughlin.
The New England Journal of Medicine (1991)
Coverage by the news media of the benefits and risks of medications
Ray Moynihan;Lisa Bero;Dennis Ross-Degnan;David Henry.
The New England Journal of Medicine (2000)
Effects of Limiting Medicaid Drug-Reimbursement Benefits on the Use of Psychotropic Agents and Acute Mental Health Services by Patients with Schizophrenia
Stephen Bertram Soumerai;Thomas J. McLaughlin;Dennis Ross-Degnan;Christina S. Casteris.
The New England Journal of Medicine (1994)
Payment Restrictions for Prescription Drugs under Medicaid
Stephen Bertram Soumerai;Jerry Lewis Avorn;Dennis Ross-Degnan;Steven L. Gortmaker.
The New England Journal of Medicine (1987)
Ten recommendations to improve use of medicines in developing countries
RO Laing;HV Hogerzeil;D Ross-Degnan.
Health Policy and Planning (2001)
A randomized trial of a program to reduce the use of psychoactive drugs in nursing homes.
Jerry Avorn;Stephen B. Soumerai;Daniel E. Everitt;Dennis Ross-Degnan.
The New England Journal of Medicine (1992)
Field tests for rational drug use in twelve developing countries
H.V. Hogerzeil;Bimo;D. Ross-Degnan;R.O. Laing.
The Lancet (1993)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: